174 related articles for article (PubMed ID: 7749848)
1. Lysine modification of LDL or lipoprotein(a) by 4-hydroxynonenal or malondialdehyde decreases platelet serotonin secretion without affecting platelet aggregability and eicosanoid formation.
Malle E; Ibovnik A; Leis HJ; Kostner GM; Verhallen PF; Sattler W
Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):377-84. PubMed ID: 7749848
[TBL] [Abstract][Full Text] [Related]
2. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein.
Requena JR; Fu MX; Ahmed MU; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):317-25. PubMed ID: 9078279
[TBL] [Abstract][Full Text] [Related]
3. LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules.
van Willigen G; Gorter G; Akkerman JW
Arterioscler Thromb; 1994 Jan; 14(1):41-6. PubMed ID: 8274476
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional changes in LDL after modification with both 4-hydroxynonenal and malondialdehyde.
Hoff HF; O'Neil J
J Lipid Res; 1993 Jul; 34(7):1209-17. PubMed ID: 8371068
[TBL] [Abstract][Full Text] [Related]
5. The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron.
Selley ML; Bartlett MR; Czeti AL; Ardlie NG
Atherosclerosis; 1998 Sep; 140(1):105-12. PubMed ID: 9733221
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a) inhibits collagen-induced aggregation of thrombocytes.
Gries A; Gries M; Wurm H; Kenner T; Ijsseldijk M; Sixma JJ; Kostner GM
Arterioscler Thromb Vasc Biol; 1996 May; 16(5):648-55. PubMed ID: 8963722
[TBL] [Abstract][Full Text] [Related]
7. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.
Fogelman AM; Shechter I; Seager J; Hokom M; Child JS; Edwards PA
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2214-8. PubMed ID: 6769124
[TBL] [Abstract][Full Text] [Related]
8. Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production.
Aviram M; Sirtori CR; Colli S; Maderna P; Morazzoni G; Tremoli E
Biochem Med; 1985 Aug; 34(1):29-36. PubMed ID: 4052061
[TBL] [Abstract][Full Text] [Related]
9. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
10. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
[TBL] [Abstract][Full Text] [Related]
11. Effect of glycation on the properties of lipoprotein(a).
Makino K; Furbee JW; Scanu AM; Fless GM
Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):385-91. PubMed ID: 7749849
[TBL] [Abstract][Full Text] [Related]
12. Effects of the lipid peroxidation product 4-hydroxynonenal on the aggregation of human platelets.
Hurst JS; Slater TF; Lang J; Juergens G; Zollner H; Esterbauer H
Chem Biol Interact; 1987 Feb; 61(2):109-24. PubMed ID: 3103933
[TBL] [Abstract][Full Text] [Related]
13. Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia.
Nofer JR; Tepel M; Kehrel B; Wierwille S; Walter M; Seedorf U; Zidek W; Assmann G
Circulation; 1997 Mar; 95(6):1370-7. PubMed ID: 9118502
[TBL] [Abstract][Full Text] [Related]
14. [Modified lipoproteins in atherosclerotic lesions of human aorta].
Wang X; Chen Q; Zhu Q
Zhonghua Bing Li Xue Za Zhi; 1998 Feb; 27(1):6-9. PubMed ID: 11244945
[TBL] [Abstract][Full Text] [Related]
15. Arachidonate transfer between platelets and lipoproteins.
Surya II; Gorter G; Akkerman JW
Thromb Haemost; 1992 Dec; 68(6):719-26. PubMed ID: 1287888
[TBL] [Abstract][Full Text] [Related]
16. Effects of dietary fish oil supplementation on platelet aggregability and platelet membrane fluidity in normolipemic subjects with and without high plasma Lp(a) concentrations.
Malle E; Sattler W; Prenner E; Leis HJ; Hermetter A; Gries A; Kostner GM
Atherosclerosis; 1991 Jun; 88(2-3):193-201. PubMed ID: 1832537
[TBL] [Abstract][Full Text] [Related]
17. Effect of 4-hydroxy-2,3-trans-nonenal on platelet function.
Selley ML; McGuiness JA; Jenkin LA; Bartlett MR; Ardlie NG
Thromb Haemost; 1988 Apr; 59(2):143-6. PubMed ID: 3133806
[TBL] [Abstract][Full Text] [Related]
18. Native and modified low-density-lipoprotein interaction with human platelets in normal and homozygous familial-hypercholesterolaemic subjects.
Shmulewitz A; Brook JG; Aviram M
Biochem J; 1984 Nov; 224(1):13-20. PubMed ID: 6508753
[TBL] [Abstract][Full Text] [Related]
19. Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination.
Chen Q; Esterbauer H; Jürgens G
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):249-54. PubMed ID: 1280111
[TBL] [Abstract][Full Text] [Related]
20. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation.
Martínez C; Rivera J; Loyau S; Corral J; González-Conejero R; Lozano ML; Vicente V; Anglés-Cano E
Thromb Haemost; 2001 Apr; 85(4):686-93. PubMed ID: 11341506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
